Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease

Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease

Source: 
Fierce Biotech
snippet: 

Mutations in more than 270 genes have been implicated in inherited eye diseases like retinitis pigmentosa. Now, Biogen has formed a research pact with Harvard’s Massachusetts Eye and Ear that’s aimed at developing a gene therapy to help some patients with these blinding diseases.